treatments to expand technological advances within the dynamic field of reproductive endocrinology and infertility. Fertility preservation for cancer patients remains a mainstream option for patients. Elective oocyte freezing for individuals who wish to delay childbearing has relatively recently been removed from the research category by the American Society for Reproductive Medicine (ASRM) and is no longer considered experimental. In our experience, this program has significantly increased over the past year. The IVF Program achieved statistics of clinical pregnancy rates approaching 50% (47.5%) in the less than 35 years/age group. (2016 Society for Assisted Reproductive Technology [SART]). Our program includes a number of patients with decreased ovarian reserve for which many programs will not offer ART/IVF. Provision of such services to this population provides the hope and realistic expectation that they too can achieve pregnancy. The In vitro Fertilization Program remains the largest in the region and serves Western Pennsylvania, Eastern Ohio, West Virginal and Western New York State. CLINICAL PROGRAMS The division continues to expand with respect to depth and breadth of clinical services. The Center for Fertility and Reproductive Endocrinology statistics 2013 2014 2015 2016 New Patients 1677 1467 1386 1905 Return Patients 4155 4191 3653 4420 The division provides clinical application of the most current evidence-based medicine for provision of care in virtually all aspects of Reproductive Endocrinology and Infertility. Acupuncture Our certified acupuncturist, Francine Desmone, has expanded the program to include infertility patients, midlife-menopausal, and most recently a gynecological oncology patient sector. The program continues to assist in pain management, stress relief and relaxation techniques including individuals undergoing assisted reproductive technologies/IVF procedures. Over the academic year 532 patients were treated. Fertility Preservation Program in Pittsburgh The Fertility preservation program at Magee-Womens Hospital provides the most comprehensive menu of fertility preservation options for women, men, girls and boys available anywhere in the United States. With expansion of standard of care as well as research options to preserve gametes, embryos and gonadal tissue as well as commitment to local, national and international outreach, the fertility preservation program has more than tripled the volume of
treatments to expand technological advances within the dynamic field of reproductive endocrinology and infertility. Fertility preservation for cancer patients remains a mainstream option for patients. Elective oocyte freezing for individuals who wish to delay childbearing has relatively recently been removed from the research category by the American Society for Reproductive Medicine (ASRM) and is no longer considered experimental. In our experience, this program has significantly increased over the past year. The IVF Program achieved statistics of clinical pregnancy rates approaching 50% (47.5%) in the less than 35 years/age group. (2016 Society for Assisted Reproductive Technology [SART]). Our program includes a number of patients with decreased ovarian reserve for which many programs will not offer ART/IVF. Provision of such services to this population provides the hope and realistic expectation that they too can achieve pregnancy. The In vitro Fertilization Program remains the largest in the region and serves Western Pennsylvania, Eastern Ohio, West Virginal and Western New York State. CLINICAL PROGRAMS The division continues to expand with respect to depth and breadth of clinical services. The Center for Fertility and Reproductive Endocrinology statistics 2013 2014 2015 2016 New Patients 1677 1467 1386 1905 Return Patients 4155 4191 3653 4420 The division provides clinical application of the most current evidence-based medicine for provision of care in virtually all aspects of Reproductive Endocrinology and Infertility. Acupuncture Our certified acupuncturist, Francine Desmone, has expanded the program to include infertility patients, midlife-menopausal, and most recently a gynecological oncology patient sector. The program continues to assist in pain management, stress relief and relaxation techniques including individuals undergoing assisted reproductive technologies/IVF procedures. Over the academic year 532 patients were treated. Fertility Preservation Program in Pittsburgh The Fertility preservation program at Magee-Womens Hospital provides the most comprehensive menu of fertility preservation options for women, men, girls and boys available anywhere in the United States. With expansion of standard of care as well as research options to preserve gametes, embryos and gonadal tissue as well as commitment to local, national and international outreach, the fertility preservation program has more than tripled the volume of
Final%20Annual%20Report%20-%20FY17.docx